Coloplast Drops as Nordea Sees Looming Threats: Copenhagen Mover

Coloplast A/S (COLOB) fell the most in three weeks in Copenhagen trading after Nordea Bank AB said government cost cutting and signs of weakening profitability may erode gains by the world’s largest ostomy products maker.

Coloplast fell as much as 2.8 percent, the steepest drop since June 24. The shares declined 9.1 kroner, or 2.6 percent, to 337.90 kroner at 2:59 p.m. in the Danish capital. Trading volume was 55 percent of the three-month daily average.

Coloplast hit a record high yesterday after climbing 13 percent since April when the Humlebaek, Denmark-based said six-month earnings before interest and tax jumped 20 percent and that it would pay an extraordinary dividend. Coloplast faces several challenges that may eat away at those gains, Jesper Bamberger, an analyst at Nordea, said today.

“It won’t take much to send the share down,” Bamberger said in a note to investors. Threats include pressure in the U.S. and France to reduce health care spending, weaker market conditions in southern Europe and signs of weakening profitability, he said.

To contact the reporter on this story: Frances Schwartzkopff in Copenhagen at fschwartzko1@bloomberg.net

To contact the editors responsible for this story: Tasneem Brogger at tbrogger@bloomberg.net; Christian Wienberg at cwienberg@bloomberg.net

Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.